# DESCRIPTION

## STATEMENT OF FEDERALLY SPONSORED RESEARCH

- disclose government support

## FIELD OF INVENTION

- define field of invention

## BACKGROUND OF INVENTION

- describe biofilm formation
- discuss problems with biofilms
- introduce diffusible signaling factors (DSF)
- discuss limitations of DSF

## SUMMARY

- introduce invention objective
- describe composition for removing biofilm
- define cyclopropanated fatty acid compounds
- outline various embodiments of composition
- describe method of preventing biofilm formation
- describe method of inhibiting biofilm formation
- outline additional aspects of invention

## DETAILED DESCRIPTION

- define terms used in the invention
- specify meaning of "a" or "an"
- define "comprising" and "another"
- specify numeric ranges and endpoints
- define "cyclopropanated" or "CP"
- define "alkyl" and its variations
- explain "substituted" and "R-substituted"
- define "substituent" and its limitations
- specify common substituents and their variations
- discuss click chemistry functionalities
- describe stereoisomers and their forms
- explain enantiomers, diastereomers, and racemates
- discuss geometric isomers and atropisomers
- specify purity and optical purity of stereoisomers
- define chemical bonding principles
- define effective amount of agent
- describe pharmaceutical composition
- describe pharmaceutical carriers
- describe pharmaceutical excipients
- define pharmaceutically acceptable salt
- define subject
- define unit dosage form
- describe cyclopropanated derivatives of fatty acids
- describe structure of compounds
- provide examples of compounds
- define pharmaceutical composition
- describe formulation techniques
- summarize routes of administration
- describe pharmaceutical forms
- list excipients for formulations
- describe controlled release formulations
- describe liquid forms for oral administration
- determine therapeutically effective amount
- describe administration regimens
- describe treatment of dental caries
- describe treatment of acne
- describe treatment of wounds
- describe kit formulations
- describe combination therapies
- describe biofilm formation
- describe surface treatment to prevent biofilm formation
- describe local drug delivery applications
- describe biomedical membranes and biomaterials

## EXAMPLES

- illustrate specific aspects of the instant description

### Example 1: Synthesis of Cyclopropanated Fatty Acid DSFs

- synthesize cyclopropanated fatty acid DSFs

### Example 2: Biofilm Dispersion Measurements (Staphyloccocus aureus)

- measure biofilm dispersion using Staphyloccocus aureus

### Example 3: Biofilm Eradication with Antibiotics

- eradicate biofilm using antibiotics and fatty acids

### Example 4: Cytocompatibility

- measure cytocompatibility of fatty acids

### Example 5: Incorporation into Biomaterials

- fabricate chitosan membranes
- load membranes with 2-CP and measure biofilm inhibition

### Example 6: Biofilm Dispersion Measurements (Pseudomonas aeruginosa)

- measure biofilm dispersion using Pseudomonas aeruginosa

### Example 7: Biofilm Inhibition

- perform synergy assays with antibiotics and 2-CP
- calculate fractional inhibitory concentration index (FICI)

### Example 8: Biofilm Eradication with Antibiotics

- eradicate biofilm using antibiotics and 2-CP
- calculate FICI for biofilm eradication

